Pfizer Limited

Ramsgate Road, Sandwich, Kent, CT13 9NJ
Telephone: +44 (0)1304 616 161
Fax: +44 (0)1304 656 221

Patient Information Leaflet last updated on the eMC: 03/10/2011
PIL Isovorin

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 03/10/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
Updated on 30/09/2011 and displayed until 03/10/2011
Reasons for adding or updating:
  • Change to date of revision
Updated on 26/08/2011 and displayed until 30/09/2011
Reasons for adding or updating:
  • Change to Marketing Authorisation Holder
Updated on 04/11/2009 and displayed until 26/08/2011
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to drug interactions
  • Change due to user-testing of patient information
Updated on 27/06/2008 and displayed until 04/11/2009
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 14/09/2007 and displayed until 27/06/2008
Reasons for adding or updating:
  • Change to date of revision
  • Correction of spelling/typing errors
Updated on 13/03/2007 and displayed until 14/09/2007
Reasons for adding or updating:
  • Change to Marketing Authorisation Holder
  • Change to date of revision
Updated on 06/08/2002 and displayed until 13/03/2007
Reasons for adding or updating:
  • Update to PIL
Updated on 21/08/2000 and displayed until 06/08/2002
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   calcium levofolinate